AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Aspen Group, Inc.

$0.24 +$0.06 (+33.33%)
OTC · 15 Sep 2026 19:24 UTC
Previous Close
$0.23
Day Range
$0.24$0.25
Year Range
$0.04$0.41
Market Cap
7.55M
AVG Volume
38.9K
Trailing/Forward PE
-3.22/-
PEG ratio
-0.05
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
05M10M15M24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
ASPU Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q410.26M
26 Q310.39M
26 Q211.22M
26 Q111.44M
25 Q411.57M
25 Q310.94M
25 Q211.46M
25 Q111.33M
24 Q410.87M
24 Q312.06M
Net Income (USD)
-10M-5M05M24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
ASPU Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q4-4.33M
26 Q31.43M
26 Q2651.74K
26 Q1406.81K
25 Q43.64M
25 Q3-908.75K
25 Q2-4.15M
25 Q1-127.86K
24 Q4-7.45M
24 Q3-3.88M
Operating Income (USD)
-3M-2M-1M01M2M24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
ASPU Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q4-927.51K
26 Q31.73M
26 Q2989.59K
26 Q1724.62K
25 Q41.36M
25 Q3383.64K
25 Q291.43K
25 Q1-615.73K
24 Q4-2.22M
24 Q3-1.77M
EBITDA (USD)
-10M-5M05M24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
ASPU EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q4-339.95K
26 Q32.34M
26 Q21.63M
26 Q11.39M
25 Q44.7M
25 Q3157.94K
25 Q2-2.96M
25 Q11.04M
24 Q4-5.62M
24 Q3-943.6K
Cash Flows (USD)
-2M-1M01M2M24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
ASPU Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q4884.84K
26 Q3863K
26 Q2300.29K
26 Q1256.46K
25 Q4432.5K
25 Q3500.69K
25 Q2-647.47K
25 Q1-52K
24 Q41.58M
24 Q3-1.67M
EPS (USD)
-0.4-0.200.224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
ASPU EPS (USD) by quarter
PeriodEPS (USD)
26 Q4-0.15
26 Q30.03
26 Q20.01
26 Q10.01
25 Q40.12
25 Q3-0.04
25 Q2-0.16
25 Q1-0.01
24 Q4-0.29
24 Q3-0.15
Expenses (USD)
02.5M5M7.5M10MSG&ACapex24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
ASPU Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q48.63M
26 Q35.61M
26 Q27.29M
26 Q17.54M
25 Q46.72M
25 Q37.06M
25 Q27.96M
25 Q18.07M
24 Q49.08M
24 Q39.39M
Cash & Debt (USD)
010M20M30MCashLong Term DebtShort Term Debt24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
ASPU Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q41.32M
26 Q3950.79K
26 Q2599.92K
26 Q1818.58K
25 Q41.07M
25 Q31.16M
25 Q21.17M
25 Q12.4M
24 Q42.62M
24 Q33.66M
Debt ratios
-10010203024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
ASPU Debt ratios by quarter
PeriodDebt ratios
26 Q43.26
26 Q31.78
26 Q22.47
26 Q16.23
25 Q47.28
25 Q3-3.03
25 Q2-2.74
25 Q1-4.51
24 Q4-5.01
24 Q320.87
Margins
0%20%40%60%80%24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
ASPU Margins by quarter
PeriodMargins
26 Q473.96%
26 Q373.95%
26 Q272.18%
26 Q170.68%
25 Q468.39%
25 Q365.81%
25 Q267.88%
25 Q163.22%
24 Q460.6%
24 Q360.37%
Return on Capital
-30%-20%-10%0%10%20%24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
ASPU Return on Capital by quarter
PeriodReturn on Capital
26 Q4-14.83%
26 Q34.28%
26 Q22.03%
26 Q11.29%
25 Q411.75%
25 Q3-3.33%
25 Q2-14.68%
25 Q1-0.4%
24 Q4-23.07%
24 Q3-13.1%
Shares Outstanding
010M20M30M40M24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
ASPU Shares Outstanding by quarter
PeriodShares Outstanding
26 Q430.09M
26 Q330.76M
26 Q229.9M
26 Q129.07M
25 Q428.39M
25 Q327.64M
25 Q226.69M
25 Q125.93M
24 Q425.7M
24 Q325.84M
Book Value Per Share (USD)
00.511.524 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
ASPU Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q40.97
26 Q31.09
26 Q21.07
26 Q11.08
25 Q41.09
25 Q30.99
25 Q21.06
25 Q11.24
24 Q41.26
24 Q31.15
Total Assets (USD)
025M50M75M100M24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
ASPU Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q460.16M
26 Q366.67M
26 Q266.38M
26 Q167.15M
25 Q466.77M
25 Q365.35M
25 Q266.34M
25 Q172.86M
24 Q475.95M
24 Q385.2M
Employee Count
01002003004002012201420152016201720182019202020212022
ASPU Employee Count by quarter
PeriodEmployee Count
2022312
2021398
2020319
2019232
2018305
2017138
201670
201553
201435
201238
PE Ratio
11.522.53med 1.52Feb 26Mar 26Apr 26May 26May 26Jun 26Jul 26
ASPU PE Ratio by quarter
PeriodPE Ratio
Jul 261.32
Jul 261.67
Jul 261.33
Jul 261.48
Jun 261.36
Jun 261.61
Jun 261.56
Jun 261.63
May 261.86
May 261.71
May 261.61
May 261.35
May 261.35
Apr 262.01
Apr 262.84
Apr 262.47
Apr 262.29
Mar 262.17
Mar 261.78
Mar 261.23
Mar 261.18
Feb 261.18
Feb 261.15
Feb 261.11
Feb 261.08
Jan 261.15
Free Cash Flow Yield
-3000%-2000%-1000%0%1000%med 14.84%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ASPU Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 2633.47%
Sep 2636.47%
Sep 2628.39%
Aug 2629.41%
Aug 2632.94%
Aug 2628.79%
Aug 2623.47%
Jul 2625.53%
Jul 2622.82%
Jul 2618.07%
Jul 2622.63%
Jul 2620.42%
Jun 2622.25%
Jun 2618.82%
Jun 2619.37%
Jun 2618.49%
May 2616.28%
May 2617.7%
May 2618.79%
May 2622.38%
May 2622.31%
Apr 2619.54%
Apr 2613.84%
Apr 2615.92%
Apr 2617.18%
Mar 2618.12%
Mar 2622.14%
Mar 2632.08%
Mar 2633.22%
Feb 2633.44%
Feb 2634.1%
Feb 2635.59%
Feb 2636.38%
Jan 2634.22%
Jan 2612.82%
Jan 2611.8%
Jan 2614.08%
Jan 2610.36%
Dec 2512.03%
Dec 259.77%
Dec 2513.32%
Dec 2512.13%
Nov 2514.35%
Nov 2515.37%
Nov 2513.5%
Nov 2517.19%
Oct 2521.2%
Oct 2510.42%
Oct 2510.29%
Oct 257.92%
Oct 257.48%
Sep 258.23%
Sep 257.79%
Sep 256.86%
Sep 2513.39%
Aug 2511.37%
Aug 2512.92%
Aug 2515.34%
Aug 2512.88%
Aug 2513.72%
Jul 2580.52%
Jul 2583.54%
Jul 2566.34%
Jul 2557.41%
Jun 2553.32%
Jun 2546.84%
Jun 2543.87%
Jun 2537.11%
May 2533.59%
May 2534.57%
May 2534.57%
May 2534.24%
May 2533.53%
Apr 25-18.61%
Apr 25-18.55%
Apr 25-19.99%
Apr 25-19.86%
Mar 25-17.46%
Mar 25-16.91%
Mar 25-16.44%
Mar 25-18.49%
Feb 25-19.72%
Feb 25-18.5%
Feb 25-21.92%
Feb 25-23.67%
Jan 25-17.36%
Jan 25-2.1%
Jan 25-2.23%
Jan 25-2.86%
Jan 25-2.38%
Dec 24-2.45%
Dec 24-2.55%
Dec 24-2.1%
Dec 24-11.83%
Nov 24-17.1%
Nov 24-17.43%
Nov 24-39.71%
Nov 24-44.68%
Nov 24-64.98%
Oct 24-2272.14%
Price to Sales
00.10.20.3med 0.09Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ASPU Price to Sales by quarter
PeriodPrice to Sales
Sep 260.16
Sep 260.15
Sep 260.19
Aug 260.18
Aug 260.16
Aug 260.18
Aug 260.23
Jul 260.21
Jul 260.18
Jul 260.23
Jul 260.18
Jul 260.2
Jun 260.19
Jun 260.22
Jun 260.21
Jun 260.22
May 260.26
May 260.23
May 260.22
May 260.19
May 260.19
Apr 260.17
Apr 260.24
Apr 260.21
Apr 260.19
Mar 260.18
Mar 260.15
Mar 260.1
Mar 260.1
Feb 260.1
Feb 260.1
Feb 260.09
Feb 260.09
Jan 260.1
Jan 260.09
Jan 260.1
Jan 260.08
Jan 260.12
Dec 250.1
Dec 250.12
Dec 250.09
Dec 250.1
Nov 250.08
Nov 250.08
Nov 250.09
Nov 250.07
Oct 250.06
Oct 250.05
Oct 250.05
Oct 250.07
Oct 250.07
Sep 250.06
Sep 250.07
Sep 250.08
Sep 250.04
Aug 250.05
Aug 250.04
Aug 250.03
Aug 250.04
Aug 250.04
Jul 250.04
Jul 250.04
Jul 250.05
Jul 250.05
Jun 250.06
Jun 250.07
Jun 250.07
Jun 250.08
May 250.09
May 250.09
May 250.09
May 250.09
May 250.09
Apr 250.09
Apr 250.09
Apr 250.09
Apr 250.09
Mar 250.1
Mar 250.1
Mar 250.11
Mar 250.09
Feb 250.09
Feb 250.09
Feb 250.08
Feb 250.07
Jan 250.1
Jan 250.09
Jan 250.09
Jan 250.07
Jan 250.08
Dec 240.08
Dec 240.08
Dec 240.09
Dec 240.02
Nov 240.01
Nov 240.01
Nov 240
Nov 240
Nov 240
Oct 240
EV/EBITDA
0100200300med 7.89Dec 23Apr 24Jul 24Nov 25Feb 26Jun 26Sep 26
ASPU EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 264.63
Sep 264.52
Sep 264.88
Aug 264.82
Aug 264.65
Aug 264.85
Aug 265.21
Jul 265.06
Jul 262.58
Jul 262.79
Jul 262.59
Jul 262.68
Jun 262.6
Jun 262.75
Jun 262.72
Jun 262.77
May 262.91
May 262.81
May 262.75
May 262.6
May 262.6
Apr 263.44
Apr 263.84
Apr 263.66
Apr 263.57
Mar 263.52
Mar 263.33
Mar 263.06
Mar 263.04
Feb 263.04
Feb 263.03
Feb 263
Feb 262.99
Jan 263.02
Jan 267.51
Jan 267.62
Jan 267.4
Jan 267.82
Dec 257.6
Dec 257.91
Dec 257.46
Dec 257.58
Nov 257.37
Nov 257.3
Nov 257.45
Nov 257.18
Oct 257
Oct 258.04
Oct 258.05
Oct 258.28
Oct 258.34
Sep 258.24
Sep 258.3
Sep 258.44
Sep 257.87
Aug 257.98
Aug 257.89
Aug 257.79
Aug 257.89
Aug 257.86
Jul 2424.54
Jul 2423.64
Jul 2423.56
Jul 2424.03
Jun 2424.03
Jun 2423.89
Jun 2423.87
Jun 2424.03
May 2424.1
May 2424.6
May 2424.74
May 2424.32
May 2425.01
Apr 2414.45
Apr 2414.81
Apr 2414.81
Apr 2414.81
Mar 2414.72
Mar 2414.7
Mar 2414.37
Mar 2414.22
Mar 2414.16
Feb 2414.29
Feb 2413.89
Feb 2413.91
Feb 2413.96
Jan 2423.04
Jan 2422.92
Jan 2422.88
Jan 2422.73
Dec 2322.73
Dec 2322.83
Dec 2322.49
Dec 2322.8
Dec 2322.81
Nov 2322.58
Nov 2322.61
Nov 2322.73
Nov 2322.43
Jul 17287.05
Price/Operating Cashflow
050100150med 2.83Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ASPU Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 262.38
Sep 262.19
Sep 262.81
Aug 262.71
Aug 262.42
Aug 262.77
Aug 263.4
Jul 263.12
Jul 263.27
Jul 264.13
Jul 263.3
Jul 263.65
Jun 263.35
Jun 263.96
Jun 263.85
Jun 264.03
May 264.58
May 264.21
May 263.97
May 263.33
May 263.34
Apr 263.39
Apr 264.79
Apr 264.16
Apr 263.86
Mar 263.66
Mar 262.99
Mar 262.07
Mar 261.99
Feb 261.98
Feb 261.94
Feb 261.86
Feb 261.82
Jan 261.94
Jan 263.04
Jan 263.3
Jan 262.76
Jan 263.76
Dec 253.23
Dec 253.98
Dec 252.92
Dec 253.21
Nov 252.71
Nov 252.53
Nov 252.88
Nov 252.26
Oct 251.84
Oct 251.88
Oct 251.9
Oct 252.47
Oct 252.61
Sep 252.38
Sep 252.51
Sep 252.85
Sep 251.46
Aug 251.72
Aug 251.51
Aug 251.28
Aug 251.52
Aug 251.43
Jul 250.7
Jul 250.67
Jul 250.85
Jul 250.98
Jun 251.05
Jun 251.2
Jun 251.28
Jun 251.51
May 251.67
May 251.62
May 251.62
May 251.64
May 251.67
Apr 2510.72
Apr 2510.75
Apr 259.98
Apr 2510.04
Mar 2511.42
Mar 2511.8
Mar 2512.14
Mar 2510.79
Feb 2510.11
Feb 2510.78
Feb 259.1
Feb 258.43
Jan 2511.49
Jan 253.74
Jan 253.52
Jan 252.75
Jan 253.3
Dec 243.21
Dec 243.08
Dec 243.74
Dec 240.66
Nov 240.46
Nov 240.45
Nov 240.2
Nov 240.18
Nov 240.12
Sep 21138.83
Price to Book
00.10.20.30.4med 0.14Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ASPU Price to Book by quarter
PeriodPrice to Book
Sep 260.24
Sep 260.22
Sep 260.28
Aug 260.27
Aug 260.24
Aug 260.27
Aug 260.34
Jul 260.31
Jul 260.24
Jul 260.31
Jul 260.24
Jul 260.27
Jun 260.25
Jun 260.29
Jun 260.29
Jun 260.3
May 260.34
May 260.31
May 260.29
May 260.25
May 260.25
Apr 260.24
Apr 260.34
Apr 260.29
Apr 260.27
Mar 260.26
Mar 260.21
Mar 260.14
Mar 260.14
Feb 260.14
Feb 260.14
Feb 260.13
Feb 260.13
Jan 260.14
Jan 260.13
Jan 260.15
Jan 260.12
Jan 260.17
Dec 250.14
Dec 250.18
Dec 250.13
Dec 250.14
Nov 250.12
Nov 250.11
Nov 250.13
Nov 250.1
Oct 250.08
Oct 250.07
Oct 250.07
Oct 250.1
Oct 250.1
Sep 250.09
Sep 250.1
Sep 250.11
Sep 250.06
Aug 250.07
Aug 250.06
Aug 250.05
Aug 250.06
Aug 250.06
Jul 250.06
Jul 250.06
Jul 250.08
Jul 250.09
Jun 250.1
Jun 250.11
Jun 250.12
Jun 250.14
May 250.15
May 250.15
May 250.15
May 250.15
May 250.15
Apr 250.15
Apr 250.15
Apr 250.14
Apr 250.14
Mar 250.16
Mar 250.17
Mar 250.17
Mar 250.15
Feb 250.14
Feb 250.15
Feb 250.13
Feb 250.12
Jan 250.16
Jan 250.14
Jan 250.13
Jan 250.1
Jan 250.12
Dec 240.12
Dec 240.11
Dec 240.14
Dec 240.02
Nov 240.02
Nov 240.02
Nov 240.01
Nov 240.01
Nov 240
Oct 240.01
Aspen Group, Inc.
ASPU
Stockpicker

Video analysis: ASPU

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ASPU

AM Best Removes From Under Review With Positive Implications and Upgrades Credit Ratings of Aspen Insurance Holdings Limited and its Rated Subsidiaries

businesswire.com · 4 Sep 2026

AM Best Removes From Under Review With Positive Implications and Upgrades Credit Ratings of Aspen Insurance Holdings Limited and its Rated Subsidiaries

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has removed from under review with positive implications and upgraded the Financial Strength Rating (FSR) to A+ (Superior) from A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) to “aa-” (Superior) from “a” (Excellent) of Aspen Insurance UK Limited (AIUK) (United Kingdom), Aspen Bermuda Limited (ABL) (Bermuda), Aspen American Insurance Company (AAIC) (Texas) and Aspen Specialty Insurance Company (ASIC) (North Dakota). The outlook assig.

Aspen sees Mounjaro Africa sales above $124 million in 2027

reuters.com · 3 Sep 2026

Aspen sees Mounjaro Africa sales above $124 million in 2027

Aspen Pharmacare expects African sales ‌of Eli Lilly's blockbuster weight-loss and diabetes drug Mounjaro to exceed 2 billion rand ($124 million) in its current financial year, buoyed by surging demand in South Africa and planned launches in ​Nigeria and Kenya.

Aspen Group Reports Fourth Quarter and Fiscal Year 2026 Results

globenewswire.com · 18 Aug 2026

Aspen Group Reports Fourth Quarter and Fiscal Year 2026 Results

United States University revenue increased 5% during Fiscal 2026, driven by solid organic lead generation Generated operating cash flow of $1.0 million in the fourth quarter, up from $0.6 million, enabling the resumption of marketing spend Gross margin expanded by 533 bps to 76% in the fourth quarter, lifting full year gross margin to 75% Fourth quarter net loss of $(4.3) million reflects two non-recurring non-cash charges totaling $3.2 million; Fiscal 2026 net loss was $(1.8) million   Record fourth quarter Adjusted EBITDA of $3.3 million, up from $2.0 million; Fiscal 2026 Adjusted EBITDA reaches $10.6 million, a Company record, up from $5.7 million PHOENIX, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Aspen Group, Inc. (OTCQB: ASPU) (“AGI” or the “Company”), an education technology holding company, today announced financial results for its fourth quarter of fiscal year 2026, ended April 30, 2026. Fourth Quarter Fiscal Year 2026 Summary Results   Three Months Ended April 30,   Years Ended April 30, $ in millions, except per share data   2026       2025       2026       2025   Revenue $ 10.3     $ 11.6     $ 43.3     $ 45.3   Gross Profit1 $ 7.8     $ 8.2     $ 32.5     $ 31.3   Gross Margin (%)1   76 %     71 %     75 %     69 % Net Income (Loss)2 $ (4.3 )   $ 0.6     $ (1.8 )   $ (1.5 ) Earnings (Loss) per Share - Basic $ (0.14 )   $ 0.02     $ (0.07 )   $ (0.07 ) Earnings (Loss) per Share - Diluted $ (0.14 )   $ 0.01     $ (0.07 )   $ (0.07 ) EBITDA3 $ (3.5 )   $ 1.7     $ 1.9     $ 2.9   Adjusted EBITDA3 $ 3.3     $ 2.0     $ 10.6     $ 5.7   _______________________ 1 GAAP gross profit calculation includes marketing, promotional and instructional costs, and amortization expense of $0.3 million and $0.4 million, and $1.5 million and $1.8 million, respectively for the three and twelve months ended April 30, 2026 and 2025, respectively.

Aspen Aerogels: Green Shoots Fail To Truly Impress Investors

seekingalpha.com · 10 Aug 2026

Aspen Aerogels: Green Shoots Fail To Truly Impress Investors

Aspen Aerogels delivered sequential revenue and EBITDA improvement, with Q2 revenues topping guidance and Q3 outlook signaling further recovery. Thermal Barrier sales rebounded sequentially, especially in Europe, but remain pressured by regulatory shifts and evolving battery technologies. ASPN's EBITDA break-even threshold lowered to $175 million in annual revenue, reflecting cost discipline and operational progress despite fire-related disruptions.

Aspen Aerogels Reminds Us Materials Science Can Be Cool, Especially If EVs Are Hot

seekingalpha.com · 10 Aug 2026

Aspen Aerogels Reminds Us Materials Science Can Be Cool, Especially If EVs Are Hot

Consider the kinds of endeavors that capture our interest. My theory: They often relate to things we can see, understand and admire in day to day life. This is probably why more children aspire to be actors than, say, accountants, and why investors gravitate more to AI or fancy tech, than say, materials science.

Aspen Aerogels Q2 Earnings Call Highlights

marketbeat.com · 7 Aug 2026

Aspen Aerogels Q2 Earnings Call Highlights

Aspen Aerogels NYSE: ASPN said it expects a sharp sequential increase in revenue and adjusted EBITDA in the third quarter, supported by energy-industrial project deliveries, rising General Motors EV production and expanding European demand for its PyroThin thermal barriers.

Aspen Aerogels, Inc. Reports Second Quarter 2026 Financial Results and Recent Business Highlights

globenewswire.com · 6 Aug 2026

Aspen Aerogels, Inc. Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Q2 2026 Thermal Barrier revenue of $29.5 million, up 81% quarter-over-quarter Q3 2026 expected revenue range of $65 to $80 million and adjusted EBITDA range of $7 to $15 million European Thermal Barrier 2026 revenue outlook raised to $20 to $30 million PyroThin® award from Jaguar Land Rover for two next-generation vehicle architectures NORTHBOROUGH, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the “Company”), a technology leader in sustainability and electrification solutions, today announced financial results for the second quarter of 2026, and discussed recent business developments.

Aspen Aerogels, Inc. to Present at the 29th Annual Oppenheimer Conference

globenewswire.com · 4 Aug 2026

Aspen Aerogels, Inc. to Present at the 29th Annual Oppenheimer Conference

NORTHBOROUGH, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the “Company”), a technology leader in sustainability and electrification solutions, today announced that the Company is scheduled to present at the 29th Annual Oppenheimer Technology, Internet & Communications Conference, to be held virtually on Tuesday, August 11, 2026.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.